RARγ1 Antibody

Skip to product information
1 of 3

Selleck Chemicals

SKU:F2634-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

RARGAMMA1 is a target of interest in many antibody-based workflows. RARγ1 is an isoform of Retinoic Acid Receptor gamma (RARγ), a nuclear hormone receptor that acts as a transcription factor upon activation by retinoic acid (RA). Structurally, it contains a ligand-binding domain, a DNA-binding domain, and a transactivation domain. RARγ1 is crucial for several developmental processes, particularly in the later phases of embryogenesis, where it regulates cellular adhesion, tissue elongation, and mesoderm development.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following RARGAMMA1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

RARGAMMA1 is commonly interpreted in the context of cancer and developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
  • co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for RARGAMMA1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in RARGAMMA1 reflect biology rather than handling. When interpreting RARGAMMA1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep RARGAMMA1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
RARGAMMA1
Research Area:
Cancer • Developmental Biology
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human • Mouse
Specificity:
RARγ1 Antibody [P15H2] recognizes endogenous levels of total RARγ1 protein. Based upon sequence alignment, this antibody is not predicted to cross-react with RARγ2. This antibody does not cross-react with either RARα or RARβ.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
P15H2
UniProt:
P13631
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.